Discover
ADMA
ADMA Biologics, Inc.
9.97
11 x 9.95
10 x 9.97
bid
ask
+
0.22
2.23%
12:30 PM
timesize
| Ytd | -45.35% | |
| 1y | -39.15% |
9.73
day range
10.01
7.21
52 week range
20.46
| Open | 9.88 | Prev Close | 9.75 | Low | 9.73 | High | 10.01 | Mkt Cap | 2.31B |
| Vol | 770.46K | Avg Vol | 3.30M | EPS | 0.71 | P/E | 14.04 | Forward P/E | 10.08 |
| Beta | 0.74 | Short Ratio | 6.89 | Inst. Own | 98.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 8.64 | 200-d Avg | 13.18 | 1yr Est | 17.00 |
| Income Statement | |||
| Total Revenue | 124.40M | ||
| Revenues (USD) | 124.40M | ||
| Cost of Revenue | 38.12M | ||
| Gross Profit | 86.28M | ||
| Operating Expenses | 33.83M | ||
| Research and Development Expense | 6.01M | ||
| Selling, General and Administrative Expense | 26.74M | ||
| Operating Income | 52.45M | ||
| Interest Expense | 3.42M | ||
| Income Tax Expense | 12.42M | ||
| Net Income | 37.82M | ||
| Net Income Common Stock | 37.82M | ||
| Net Income Common Stock (USD) | 37.82M | ||
| Consolidated Income | 37.82M | ||
| Earnings per Basic Share | 0.17 | ||
| Earnings per Basic Share (USD) | 0.17 | ||
| Earnings per Diluted Share | 0.16 | ||
| Earning Before Interest & Taxes (EBIT) | 53.66M | ||
| Earning Before Interest & Taxes (USD) | 53.66M | ||
| Weighted Average Shares | 228.23M | ||
| Weighted Average Shares Diluted | 230.34M | ||
| Balance Sheet | |||
| Cash and Equivalents | 136.02M | ||
| Cash and Equivalents (USD) | 136.02M | ||
| Trade and Non-Trade Receivables | 138.23M | ||
| Current Assets | 528.20M | ||
| Property, Plant & Equipment Net | 72.81M | ||
| Total Assets | 684.21M | ||
| Debt Current | 4.93M | ||
| Total Debt | 197.77M | ||
| Current Liabilities | 75.76M | ||
| Debt Non-Current | 192.84M | ||
| Total Liabilities | 276.00M | ||
| Accumulated Retained Earnings (Deficit) | -78.50M | ||
| Shareholders Equity | 408.21M | ||
| Shareholders Equity (USD) | 408.21M | ||
| Assets Non-Current | 156.01M | ||
| Total Debt (USD) | 197.77M | ||
| Deferred Revenue | 1.33M | ||
| Goodwill and Intangible Assets | 4.11M | ||
| Inventory | 239.31M | ||
| Liabilities Non-Current | 200.25M | ||
| Trade and Non-Trade Payables | 31.72M | ||
| Tax Assets | 69.97M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.78M | ||
| Net Cash Flow from Financing | -29.42M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.13M | ||
| Capital Expenditure | -2.26M | ||
| Issuance (Purchase) of Equity Shares | -25.02M | ||
| Issuance (Repayment) of Debt Securities | -469.00K | ||
| Net Cash Flow from Investing | -2.26M | ||
| Net Cash Flow from Operations | 29.54M | ||
| Share Based Compensation | 6.14M | ||